Browse Articles

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Global Forum

Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies
Zheng Su
Drug Information Journal

Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies
Drug Information Journal

Review of: Fundamentals of US Regulatory Affairs, 7th ed.
Edward Tabor
Drug Information Journal

Certification for the Medical Science Liaison: An Idea Whose Time Has come---or Not
Kenneth L Massey,Jane Chin,Jimmy Thomas Black
Drug Information Journal

Medical Information Services in the Age of Social Media and New Customer Channels
Lesley S. Fierro,Poonam A. Bordoloi,Michelle Clausen,Krupa Paranjpe,Andrew Gazo
Drug Information Journal

Clinically Important Effects in New Drug Development
Satoshi Hashigaki,Kanae Togo,Takashi Moriya,Keiji Imai
Drug Information Journal

Assessment of Electronic Drug Information Research Availability in Alabama Pharmacies
Michael G Kendrach,Bob Schrimsher,Maisha Kelly Freeman
Drug Information Journal

Content Analysis of Off-label Drug Use: Reporting Print Media Coverage
David A. Holdford,Avani D Joshi
Drug Information Journal

Failure to Communicate: Medication Guide or Memory ?
Louis A Morris,Morris S Whitcup
Drug Information Journal

Evaluation of Drug Adverse Event Intake and Reporting in a Medical Information Service
Robert J. Fuentes,Michael Hoopes,Gregory M Susla,Pamela D Allen
Drug Information Journal

Validation of Decision-enabling Tools: Showing That the Model Is Useful
Stig J Wiklund
Drug Information Journal

A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making
Andreas I. Sashegyi
Drug Information Journal

Letter to the Editor: Selection of the Time Points for a Thorough QTc Study
Norman Stockbridge,Joanne Zhang
Drug Information Journal

A Longitudinal Model and Graphic for Benefit-risk Analysis, With Case Study
Jonathan D. Norton
Drug Information Journal

Platelet Aggregation Quality Control in a Multicenter Phase 2 Clinical Trial
James McRedmond
Drug Information Journal

Ten-year Experience of the Evaluation of Ethnic Sensitivity Data
Chia-Ling Hsiao
Drug Information Journal

Letter to the Editor
Drug Information Journal

Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and Wealth
Peter J. Pitts
Drug Information Journal

Preparing for a Safety Inspection
Steve Jolley
Drug Information Journal

Associate Editor's Commentary: The Danger of Shorting Drug Shortages
Peter J. Pitts
Drug Information Journal

Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk- Benefit Assessment
John Doyle
Drug Information Journal

Editor's Commentary: A Time for Reflection and Anticipation
Rick Turner
Drug Information Journal

Benefit/Risk Estimates in Clinical Trials
Adil E. Shamoo
Drug Information Journal

Japanese Guideline on Global Clinical Trials: Statistical Implications and Alternative Criteria for Assessing Consistency
Florence Le Maulf,Kevin J. Carroll
Drug Information Journal

Decision Making for a Companion Diagnostic in an Oncology Clinical Development Program
Bernard Fine,Lee Kaiser
Drug Information Journal

Establishing a Complete Drug Information Triad: Academic, Industry, and Hospital Training
Elizabeth S Miller,Katie J. Suda,Anne M. Hurley,Mina Tadrous,Daniel Gharbawy
Drug Information Journal

Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec
Benoit Rouleau
Drug Information Journal

Technical Requirements for Biopharmaceutics Classification System–based Biowaiver in China
Ning Zhang
Drug Information Journal

Results of a Survey of PhRMA Member Companies on Practices Associated With Multiregional Clinical Trials
Nick R Scott,Tonya L Houck,Yoko Tanaka,Bruce Binkowitz,Belinda Field,Ekopimo O. Ibia,Andy Lee,Steven Talerico
Drug Information Journal

Consistency of Treatment Effect Across Regions in Multiregional Clinical Trials, Part 2: Monitoring, Reporting, and Interpretation
Soo P. Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi Ikeda
Drug Information Journal

Consistency of Treatment Effect Across Regions in Multiregional Clinical Trials, Part 1: Design Considerations
Soo P. Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi Ikeda
Drug Information Journal

Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials
Cynthia J. Girman,Shailendra S. Menjoge,Bruce Binkowitz,Carmen Mak,Anupam Agarwal,Ekopimo O. Ibia,Joshua Chen
Drug Information Journal

Points to Consider in Defining Region for a Multiregional Clinical Trial: Defining Region Work Stream in PhRMA MRCT Key Issue Team
Michael A Rabbia,Yoko Tanaka,Bruce Binkowitz,Carmen Mak,Ekopimo O. Ibia,Brent Burger,Joshua Chen,Alex Zolotovitski
Drug Information Journal

Multiregional Clinical Trials: An Introduction From an Industry Perspective
Bruce Binkowitz,Ekopimo O. Ibia
Drug Information Journal

Letters to the Editor
Norman Stockbridge,Lawrence Z Satin,Eoin O'Brien
Drug Information Journal

Program Chair Reflects Upon DIA 2011
Kenneth A. Getz
Drug Information Journal

Editor's Commentary: Letters to the Editor, a New Publishing Partner, and Benefit-risk Estimation
Rick Turner
Drug Information Journal

DIA 2011 47th Annual Meeting Student Poster Abstracts
Nicholas H. Schluterman,Anne-Sophie Auroux,Mohammed Hamdan Al Rubaie,Jie Rena Sun,Jingjing Liu,Kaushal Vinaykumar Sheth,Gabriel Meister,Brian Claggett,Danish Arora,Manasi Datar,Shaunak Praful Kulkarni,Michelle P. Pernice,Andrew W. York,Digvijay Chandrakant Yeola,Joseph Mburu,Nikita Somani
Drug Information Journal

Expediting Patient Access to New Medicines: A Call to Action, London, January 26-27, 2010
Peter J. Pitts,Werner Cautreels,Mary Baker
Drug Information Journal

5th Annual Cardiovascular Risk Assessment Summit
Lawrence Z Satin,David E. Gutstein
Drug Information Journal

Review of the 9th Middle East Regulatory Conference
Adrian Ball,Mike Stuart Fallows
Drug Information Journal

Review of International Pharmaceutical Product Registration, 2nd ed.
Edward Tabor
Drug Information Journal

Implementation of an Electronic Medical Information Request System for Field-generated Information Inquiries
Rommel Fernandez,Barbara Schreiner,Edward Bezarro,Helen Yin Yu,Jimmy Thomas Black
Drug Information Journal

Effect of Direct-to-Consumer Drug Advertising Exposure on Information Search
Clive Mario Mendonca,David J McCaffrey,Benjamin F. Banahan III,Jonn P. Bently,Yi Yang
Drug Information Journal

Using Real-time Data to Drive Better Decisions, Faster
Paula Brown Stafford,Andrew Garrett
Drug Information Journal

Covariate-adjusted Difference in Proportions From Clinical Trials Using Logistic Regression and Weighted Risk Differences
Miaomiao Ge,L. Kathryn Durham,R. Daniel Meyer,Wangang Xie,Neal Thomas
Drug Information Journal

Multiple-stage Sampling Procedure for Lot Release With Consideration of oth Manufacturer's and Consumer's Risk
Boguang Zhen,Tie-Hua Ng,Henry Hsu
Drug Information Journal

Optimal Sample Size Allocation in a Thorough QTc Study
Joanne Zhang
Drug Information Journal

Are Pharmacists a Viable Channel for Education About Clinical Trial Participation?
Diane Simmons,Jill Chappell,Kenneth A. Getz,Zachary P Hallinan,Brian P. Schrock,Dorothy L Smith
Drug Information Journal

Phase 2 Clinical Development in Treating Chronic Diseases
Naitee Ting
Drug Information Journal

Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database
Jules T. Mitchel,Yong Joong Kim,Joonhyuk Choi,Glen D Park,Silvana Cappi,David Horn,Morgan Kist,Ralph B. D'Agostino
Drug Information Journal

Variability in Protocol Design Complexity by Phase and Therapeutic Area
Kenneth A. Getz,Rafael A. Campo,Kenneth I. Kaitin
Drug Information Journal

Editor's Commentary: Additional Associate Editors, New Submission Category, and Meta-methodology
Rick Turner
Drug Information Journal

Proceedings of the DIA WOrkshop on Multiregional Clinical Trials, October 26-27, 2010
Ekopimo O. Ibia,Bruce Binkowitz
Drug Information Journal

Factors Influencing Investigative SIte Willingness and Ability to Participate in Clinical Trials
Mary Jo Lamberti,Rachael Zuckerman,Deborah Howe,Lisa E. Shapiro,Kenneth A. Getz
Drug Information Journal

Assessing a Drug's Proarrhythmic Liability: An Oerview of Computer SImulation Modeling, Nonclinical Assays, and the Thorough QT/QTc Study
Lawrence Z Satin,Timothy Lee Durham,Rick Turner
Drug Information Journal

Time-Cost Optimization of Complex Clinical Trials
Douglas Gregory
Drug Information Journal

Call Handling in the Pharmaceutical Industry: A Benchmarking Survey
Catherine J Nojiri,Chandni Patel
Drug Information Journal

Conditional Type I Error Rate for Superiority Test Conditioned on Establishment of Noninferiority in Clinical Trials
Jason Yuan,Tiejun Tong,Tie-Hua Ng
Drug Information Journal

A Two-Stage Adaptive Design in Phase 2 Clinical Trials for Acute Treatment of Migraine
Xiaoyin Frank Fan,Chris Assaid,Yang Joy Ge,Tony W. Ho
Drug Information Journal

Statistical Analysis for Long-term Stability Studies with Multiple Storage Conditions
Edwin Van den Heuvel,Osama Almalik,Michiel Nijhuis,Edward I. Warner
Drug Information Journal

A Meta-analysis to Asess the FDA DAVP's TLOVR Algorithm in HIV Submissions
Fraser Smith,Thomas Hammerstrom,Greg Soon,Susan Y Zhou,Baibai Chen,Yabling Mai,Kimberly A. Struble,Mohammad Huque
Drug Information Journal

The Physicians' Labeling Rule: An Evaluation of Compliance
Amy L. Ebel,Thomas G Cantu,Stuart Hobbs,Paula R. Rogenes,Melissa H Beaman,MaryAnn E Ziemba
Drug Information Journal

Measuring the Incidence, Causes, and Repercussions of Protocol Amendments
Kenneth A. Getz,Rachael Zuckerman,Anne B. Cropp,Anna L Hindle,Randy Krauss,Kenneth I. Kaitin
Drug Information Journal

Substantial Evidence: When is a Single Trial Sufficient for Approval and Promotion?
David Coutant,David Riggs,Elizabeth Van Sant Hoffman
Drug Information Journal

FDAAA Basic Results Reporting: First Experience and Challenges
Hans-Theo Forst,Robert Paarlberg,Elizabeth Roberts
Drug Information Journal

Focus on the Cardia Safety Research Consortium
Mitchell W. Krucoff
Drug Information Journal

Why ABPM Should Be Mandatory in All Trials of Blood Pressure - Lowering Drugs
Eoin O'Brien
Drug Information Journal

Associates Editor's Commentary: Innovation Nation
Peter J. Pitts
Drug Information Journal

Editor's Commentary: Regulatory Science and the Science of Safety
Rick Turner
Drug Information Journal

Global Pharmaceutical Forum (In Chinese)

Global Pharmaceutical Forum (In Chinese)

Global Pharmaceutical Forum (In Chinese)

Global Pharmaceutical Forum (In Chinese)

Global Pharmaceutical Forum (In Chinese)

Global Pharmaceutical Forum (In Chinese)

Global Pharmaceutical Forum (In Chinese)